Inhibition of neutral endopeptidase increases airway responsiveness to ACh in nonsensitized normal rats.
The effects of sensory neuropeptides on the airway responsiveness to acetylcholine (ACh) were investigated in normal nonsensitized rats. The airway responsiveness to inhaled ACh was significantly increased after treatment with neurokinin A (NKA; 0.001%) or substance P (SP; 0.01%) aerosol in the presence of the neutral endopeptidase (NEP) inhibitor. NKA had a more potent effect than SP. Interestingly, the intravenous treatment with NEP inhibitor alone also induced airway hyperresponsiveness (AHR) to inhaled ACh. This AHR was significantly attenuated by pretreatment with a nonselective NK-receptor antagonist, [D-Pro2,D-Trp7,9]SP, systemic capsaicin, or bilateral cervical vagotomy, indicating that decreased NEP activity results in accumulation of endogenous sensory neuropeptide(s) and enhancement of vagal reflex to cause AHR. The airway responsiveness to ACh of isolated left main bronchus was also increased after treatment with 10(-6) M NKA, but not SP, together with 10(-6) M phosphoramidon. This in vitro AHR to ACh induced by phosphoramidon plus NKA was significantly attenuated by pretreatment with 10(-6) M tetrodotoxin. These findings suggest that overaccumulated sensory neuropeptides, especially NKA, may enhance the probability of transmitter release, probably via NK2 receptors, and that the enhanced transmitter release might be involved in AHR in rats.
Chiba
Y
Y
Department of Pharmacology, School of Pharmacy, Hoshi University, Tokyo, Japan.
Misawa
M
M
D000109:Acetylcholine / Q000494:pharmacology*; D000280:Administration, Inhalation; D000818:Animals; D016535:Bronchial Hyperreactivity / Q000503:physiopathology; D002199:Capillary Permeability / Q000187:drug effects; D002211:Capsaicin / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D006020:Glycopeptides / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects; D015260:Neprilysin / Q000037:antagonists & inhibitors*; D015288:Neurokinin A / Q000008:administration & dosage / Q000494:pharmacology; D011480:Protease Inhibitors / Q000494:pharmacology; D011813:Quinuclidinyl Benzilate; D051381:Rats; D017208:Rats, Wistar; D012137:Respiratory System / Q000187:drug effects*; D013373:Substance P / Q000008:administration & dosage / Q000494:pharmacology; D014628:Vagotomy
D006020:Glycopeptides; D011480:Protease Inhibitors; D013373:Substance P; D011813:Quinuclidinyl Benzilate; D015288:Neurokinin A; D002217:Carbachol; D015260:Neprilysin; D000109:Acetylcholine; D002211:Capsaicin; C008890:phosphoramidon